RxDoctor Payments Data

Colleen Maher, DO

Family Medicine · Aurora, CONPI 1326625229

Payments from drug & device makers

$227in general payments, 2019–2025

Across 12 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$68
  • Pfizer$34
  • Sumitomo Pharma America, Inc.$27
  • Phadia US Inc.$24
  • 180 Medical, Inc.$22
  • GSK$19
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC4$68
Pfizer2$34
Sumitomo Pharma America, Inc.1$27
Phadia US Inc.1$24
180 Medical, Inc.1$22
GSK1$19
UCB, Inc.1$19
Novo Nordisk1$14

How this compares

$227 in reported general payments places this provider in the 60th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$5,963
Medicare patients
29
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →